About
Cellergy is producing a large quantity of mitochondrial product from human primary sources for systemic, repeated administration, using fully matched allogeneic purified mitochondria delivered via IV for major systemic indications such as CNS disorders, muscle degeneration, and aging.
Its breakthrough approach harnesses the power of young, healthy mitochondria to revolutionize the treatment of degenerative and metabolic diseases. Through innovative mitochondrial transplantation therapy, Cellergy replaces compromised mitochondria with fully functional ones, effectively restoring cellular energy production and enhancing cell function.
The company is transforming human health by providing the power of young and healthy mitochondria to energize cells, fight degenerative diseases and enhance healthy longevity.
Funding history · 1 round · — total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- When was Cellergy Therapeutics founded?
- Cellergy Therapeutics was founded in May 2021.
- Where is Cellergy Therapeutics headquartered?
- Cellergy Therapeutics is headquartered in Yavne, Israel.
- What is Cellergy Therapeutics' primary focus?
- Cellergy Therapeutics focuses on producing mitochondrial products from human primary sources for systemic administration, aiming to treat CNS disorders, muscle degeneration, and aging through mitochondrial transplantation therapy.
- What is the current employee count for Cellergy Therapeutics?
- Cellergy Therapeutics currently has 8 employees.
- What is the latest funding round for Cellergy Therapeutics?
- Cellergy Therapeutics completed a Seed round in September 2025, with participation from XT Group and Fresh Fund. For full financing history, refer to startupim.
- What is Cellergy Therapeutics' current product stage?
- Cellergy Therapeutics is currently in the R&D product stage.
- What is Cellergy Therapeutics' primary sector?
- Cellergy Therapeutics' primary sector is Health Tech & Life Sciences.
- Has Cellergy Therapeutics been featured in any news?
- Yes, on May 18, 2025, Haaretz.com published an article titled 'MITOCHONDRIA: THE NEW FRONTIER IN HEALING A MEDICAL BREAKTHROUGH' about Cellergy Therapeutics.